Skip to main content

RT @uptoTate: Abs 1507 at #ACR22 demonstrated that even a 6-month delay in PsA dx from symptom onset contributes to wor

Social Author Name
Dr. Rachel Tate
Tweet Content
Abs 1507 at #ACR22 demonstrated that even a 6-month delay in PsA dx from symptom onset contributes to worse patient-reported outcomes measures on overall quality of life. @RheumNow https://t.co/qLOwE9rImz https://t.co/nacdjz5pCy
Show on Archive Page
On
Display in Search Results
On
PDQ
Off